BCL2L1 and ovarian cancer: Real-time PCR experiments were performed using bcl-xl-, bax-, akt-, caspase-3-, CDC25C- and cyclinB1-specific primers to assess their relative mRNA expressions (2-ΔΔCt) in human primary ovarian cancer cells treated with ACFP for 48 h (Fig. 6a).